|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘 | Saif M W Elfiky A Diasio R | 2006 | Clin Colorectal Cancer2006，6，3： | 1 |
| 2 | A phase1study of everoiimus and docetaxel in patients with cas-tration-resistant prostate cancer 显示文摘 | Courtney K D Manola J B Elfiky A A | 2015 | Clin GenitourinCancer2015，13，2： | 1 |
| 3 | Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘 | Saif M W Elfiky A Diasio R | 2006 | Clin Colorectal Cancer2006，6，3： | 1 |
| 4 | Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine显示文摘 | Saif MW Elfiky A Diasio R | 2006 | Clin Colorectal Cancer2006，6，3： | 1 |
| 5 | Novel molecular targets for the therapy of renal cell carcinoma显示文摘 | Elfiky AA Sonpavde G | 2012 | Dis Med2012，13，73： | 1 |
| 6 | Discriminative compact pyramids for object and scene recognition显示文摘 | ELFIKY N M KHAN F S VAN de WEIJER J | 2012 | Pattern Recognition2012，45，4： | 1 |
| 7 | Gastrointestinal perforation due to bevacizumab in colorectal cancer显示文摘 | Saif MW Elfiky A Salem RR | 2007 | Ann Surg Oncol2007，14，6： | 1 |
| 8 | Novel molecular targets for the therapy of renal cell carcinoma显示文摘 | Elfiky AA Sonpavde G | 2012 | Discov Med2012，13，13： | 1 |
| 9 | Hand and foot syndrome variant in a dihydropyrinidine dehydrogenase -deficient patient treated with capecitabine显示文摘 | Saif M W Elfiky A Diasio R | 2006 | Clin Colorectal Cancer2006，6，3： | 1 |
| 10 | Gastrointestinal perforation due to be- vacizumab in colorectal cancer显示文摘 | Saif MW Elfiky A Salem RR | 2007 | Ann Surg Onco12007，14，6： | 1 |
| 11 | Assessment of circulating levels of microRNA-326,microRNA-424,and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians显示文摘BACKGROUND Hepatocellular carcinoma(HCC)is the fifth most common cancer.Differential expression of microRNAs(miRNAs)-326,miRNA-424,and miRNA-511 has been associated with the diagnosis and prognosis of HCC in different populations.However,limited information is available regarding their expression in Egyptian HCC patients.AIM To assess the role of circulating miRNAs-326,miRNA-424,and miRNA-511 in Egyptian HCC patients.METHODS This prospective observational study included 70 HCC patients and 25 healthy controls.The circulating levels of these three miRNAs were evaluated by real-time PCR.Receiver operating characteristic curve analysis was used to test the diagnostic accuracy of micro RNA expression levels.RESULTS All miRNAs were differentially expressed in HCC patients;miRNAs326 and miRNA-424 were upregulated,while miRNA-511 was downregulated.Both miRNA-326 and miRNA-424 showed sensitivity and specificity of 97%,71.4%,and 52%,60%,respectively,to differentiate HCC from controls.Moreover,miRNA-326 was associated with survival and could differentiate between Child grades(A vs B);miRNA-424 significantly differentiated early vs intermediate stages of HCC;while miRNA-511 was significantly correlated with response to modified Response Evaluation Criteria in Solid Tumors(m RECIST).CONCLUSION We conclude that miRNA-326,miRNA-424,and miRNA-511 have diagnostic and prognostic roles in Egyptian patients with hepatitis C virus-related HCC and should be considered for better disease management. | Samar Samir Youssef Asmaa Elfiky Mohamed M Nabeel Hend Ibrahim Shousha Tamer Elbaz Dalia Omran Mohammad Saeed Marie Mohammad A Elzahry Amr Abul-Fotouh Ahmed Hashem Mohamed F Guda Ashraf O Abdelaziz | 2022 | World Journal of Hepatology2022，14，8： | 1 |
| 12 | Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal 显示文摘 | ELFIKY A A AZIZ S A | 2011 | J Transl Med2011，9，： | 1 |
| 13 | Gastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer显示文摘 | Muhammad Wasif Saif Aymen Elfiky Ronald R. Salem | 2007 | Annals of Surgical Oncology2007，，6： | 1 |
| 14 | Gastrointestinal per foration due to bevacizumab in colorectal cancer显示文摘 | Saif MW Elfiky A Salem RR | 2007 | Ann Surg Oncol2007，14，6： | 1 |
| 15 | Novel molecular targets for the therapy of renal cell carcinoma显示文摘 | Elfiky AA Sonpavde G | | 0，，73： | 1 |
| 16 | Gastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer显示文摘 | Muhammad Wasif Saif MD MBBS Aymen Elfiky MD Ronald R. Salem MB ChB | 2007 | Annals of Surgical Oncology2007，，6： | 1 |
| 17 | Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase deficient patient treated with capecitabine显示文摘 | Saif M W Elfiky A Diasio R | 2006 | Clin Colorectal Cancer2006，6，3： | 1 |
| 18 | Discriminative compact pyramids for object and scene recognition 显示文摘 | Elfiky N M Khan F S Van de Weijer J | 2012 | Pattern Recognition2012，45，4： | 1 |
| 19 | Effect of base doping concentration on radiation-resistance for Ga As sub-cells in In Ga P/Ga As/Ge显示文摘 | ELFIKY D YAMAGUCHI M SASAKI T | 2010 | Japanese Journal of Applied Physics2010，49，12： | 1 |
| 20 | Targeting angiogenesisin bladder cancer显示文摘 | Elfiky AA Rosenberg JE | 2009 | Curr Oncol Rep2009，11，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员